光热治疗
三苯胺
呋喃
化学
荧光
纳米技术
光化学
量子产额
合理设计
分子
材料科学
分子间力
小分子
组合化学
产量(工程)
发光
噻吩
聚集诱导发射
纳米颗粒
光致发光
单线态氧
光热效应
作者
Ji Liu,Kaizhen Wang,Jiaqiao Li,Xiao Liu,Jingjing Lin,Shiya Wang,Pengbo Wang,Anran Chu,Minxuan Xiong,Yiyang Zhou,Dongwei Liu,Chenyi Yang,Fengyan Song,Qifeng Zhong,Zhenwei Yuan
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia represents a critical threat owing to its high mortality and antibiotic resistance. Near-infrared II (NIR-II) fluorescent photothermal therapy (PTT) enables deep-tissue heating but risks incomplete bacterial clearance and thermal damage. Symmetric donor-acceptor-donor (D-A-D) NIR-II molecules often suffer from high molecular weights, low fluorescence, and suboptimal photothermal conversion. Herein, we report asymmetric D-A-π-D NIR-II aggregation-induced emission luminogens (AIEgens) featuring a benzothiopyrylium acceptor, triphenylamine donors, and furan or thiophene as π-bridge. Furan strengthens non-covalent conformation locking while weakening intermolecular π-π stacking, thereby enhancing both fluorescence and photothermal performance. AIEgen 4fop achieves an optimal photothermal conversion efficiency of 84.3% and a NIR-II photoluminescence quantum yield of 2.31% in toluene. To boost antibacterial activity, 4fop was co-encapsulated with the thermally responsive NO donor BNN6 into Pluronic F-127 nanoparticles. In a murine pneumonia model, this nanoplatform substantially reduces bacterial burden, suppresses inflammation through TNF pathway modulation, and promotes lung repair. This work establishes a rational D-A-π-D design strategy and an integrated nanoplatform for the precise treatment of deep-seated drug-resistant infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI